Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sangamo Therapeutics
Biotech
Lilly saves gene therapy biotech with $18M upfront deal
Sangamo can earn up to $1.4 billion in fees and milestones, as well as tiered royalties, if Lilly opts to pursue all five possible targets.
Darren Incorvaia
Apr 3, 2025 6:00pm
Pfizer crashes Sangamo's stock by ending hem A gene therapy pact
Jan 2, 2025 6:08am
Astellas pays Sangamo $20M to boost neurological gene therapies
Dec 19, 2024 7:13am
Sangamo slashes time to market for Fabry gene therapy
Oct 22, 2024 12:57pm
Genentech offers Sangamo $2B+ biobucks in neuro licensing deal
Aug 6, 2024 8:05am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
